ArQule (ARQL) Stock: Rocketing On Clinical Data
ArQule, Inc. (NASDAQ: ARQL) is having a great start to the trading session this morning, and for good reason. The company announced preliminary results from an ongoing Phase 1 study. Of course, the results were positive, exciting investors and sending the stock for the top. Today, we’ll talk about: The clinical data; what we’re seeing … Read more